netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 30 of 44

Older Oldest

Details
UPD sitematrix Changed from 0 to
14/03/2024 14:42:46
(DavidS )
UPD drugExtra Changed from SGLT2 inhibitor to
14/03/2024 14:42:46
(DavidS )
UPD Dapagliflozin (Forxiga®) updated
14/03/2024 14:42:46
(DavidS )
DUP Item ID 4366 : Moved from 06.01.02.03 to 06.01.02.03
30/01/2024 14:55:56
(DavidS )
UPD sitematrix Changed from 0 to
20/11/2023 11:32:20
(DavidS )
UPD FurtherInformation Changed from
20/11/2023 11:32:20
(DavidS )
UPD Dapagliflozin (Forxiga®) Moved HF indication to cha[pter 02.15
20/11/2023 11:32:20
(DavidS )
UPD sitematrix Changed from 0 to
10/07/2023 15:00:55
(dmcdermott )
UPD drugExtra Changed from to SGLT2 inhibitor
10/07/2023 15:00:55
(dmcdermott )
UPD Dapagliflozin (Forxiga®) #
10/07/2023 15:00:55
(dmcdermott )
UPD sitematrix Changed from 0 to
10/07/2023 15:00:51
(dmcdermott )
UPD drugExtra Changed from to SGLT2 inhibitor
10/07/2023 15:00:51
(dmcdermott )
UPD Dapagliflozin (Forxiga®) #
10/07/2023 15:00:51
(dmcdermott )
LDL Link 19593 Deleted : 06.01.02.03 : https://ntag.nhs.uk/wp-content/uploads/2022/06/Dapagliflozin-in-CKD-Top-Tips-NTAG-v1-approved-June-2022.pdf
14/07/2022 12:55:30
(DavidS )
LDL Link Added : NTAG: Top Tips and Recommendations for Dapagliflozin [FORXIGA] in Chronic Kidney Disease (CKD) : https://ntag.nhs.uk/wp-content/uploads/2022/06/Dapagliflozin-in-CKD-Top-Tips-NTAG-v1-approved-June-2022.pdf
14/07/2022 12:53:11
(DavidS )
UPD sitematrix Changed from 0 to
14/07/2022 12:52:42
(DavidS )
UPD FurtherInformation Changed from

  • 5mg and 10mg tablets

    • Approved for treating type 2 diabetes in adults Green  
14/07/2022 12:52:42
(DavidS )
UPD Dapagliflozin (Forxiga®) updated
14/07/2022 12:52:42
(DavidS )
UPD sitematrix Changed from 0 to
12/05/2022 11:03:08
(DavidS )
UPD FurtherInformation Changed from
12/05/2022 11:03:08
(DavidS )
UPD Dapagliflozin (Forxiga®) updated
12/05/2022 11:03:08
(DavidS )
LDL Link 19424 Deleted : 06.01.02.03 : https://www.nice.org.uk/guidance/ta597
26/04/2022 13:56:24
(DavidS )
UPD sitematrix Changed from 0 to
26/04/2022 13:56:10
(DavidS )
UPD FurtherInformation Changed from
26/04/2022 13:56:10
(DavidS )
UPD Dapagliflozin (Forxiga®) Removal of type 1 diabetes - license change
26/04/2022 13:56:10
(DavidS )
LDL Link Added : NICE TA775: Dapagliflozin for treating chronic kidney disease : https://www.nice.org.uk/guidance/ta775
26/04/2022 13:02:51
(DavidS )
UPD sitematrix Changed from 0 to
26/04/2022 13:02:29
(DavidS )
UPD isDraft Changed from N to Y
26/04/2022 13:02:29
(DavidS )
UPD FurtherInformation Changed from
26/04/2022 13:02:29
(DavidS )
UPD Dapagliflozin (Forxiga®) NICE TA775. APC - April 2022
26/04/2022 13:02:29
(DavidS )

 

 
netFormulary